Currently not available for sale in Canada.
This control is formulated for use as an unassayed serum control with in vitro diagnostic test kits for the qualitative detection of IgM antibodies to Borrelia burgdorferi (Lyme Disease). ACCURUN 132 is manufactured from human serum or plasma, reactive for anti-Borrelia burgdorferi. For in vitro diagnostic use.
Product Literature